Because of the known anxiolytic and analgesic effects of eCBs and CB11 activation, the more-rapid loss of CB1 in stressed adolescent female brains is consistent with the clinical observations of a greater prevalence and higher severity of anxiety symptoms such as increased sensitivity to fear signals, emotional disturbance, and pain in females after chronic stress exposure (72–76). The gene discussed is CNR1; the disease is Anxiety.